Bruin Biometrics, LLC, a Spin-Out from UCLA, to Demonstrate Its First Prototype Wireless Health Device for Detecting Sub-Epidermal Moisture and Use in Wound Care Management at Wireless Health 2010 - La Jolla, California

Wireless Health 2010

LOS ANGELES--()--Bruin Biometrics, LLC (“BBI”) announced today it is demonstrating its breakthrough technology at Wireless Health 2010, October 5-7 in La Jolla, California (http://www.wirelesshealth2010.org/). Wireless Health 2010 is an industry-leading conference focused on the convergence of science, mobile technology and medicine and cutting edge research from around the world. It will feature distinguished speakers and leaders from industry, medicine, academia, U.S. Department of Homeland Security, U.S. Food and Drug Administration, among others together with demonstrations of emerging technologies and products.

BBI was spun-out of UCLA, Henry Samueli School of Engineering and Applied Science and Wireless Health Institute in May 2009. BBI was co-founded by William J. Kaiser, Ph.D, Professor, Electrical Engineering and co-founder of UCLA’s Wireless Health Institute, Majid Sarrafzadeh, Ph.D, Professor, Computer Science and Electrical Engineering and co-founder of UCLA’s Wireless Health Institute, Joseph A. Boystak, President & CEO of Brightwaters Capital, LLC and Michael B. Flesch.

“BBI has made remarkable process since its inception,” stated Joseph A. Boystak, Co-Founder and Managing Member of BBI; “we have taken this technology from concept to reference design/functioning prototype of our first device – the Sub-Epidermal Moisture Scanner, known as the SEM Scanner, developed proprietary software, successfully completed a 30-person healthy subject trial at UCLA and are currently participating in a multi-site nursing home clinical trial aimed at improving skin health under the aegis of Dr. Barbara Bates-Jensen, Principal Investigator and Associate Professor, UCLA Schools of Nursing and Medicine – all within 18 months.”

The market for BBI’s wireless technology is significant and growing according to industry estimates. Its first product – the SEM Scanner is intended for use in measuring sub-epidermal moisture that may be indicative of developing pressure ulcers (sometimes referred to as bedsores). Dr. Bates-Jensen states, “The SEM Scanner may provide information that enables clinicians to intervene very early to prevent actual damage to the skin and the onset of a serious wound compared to visual observation which is the current standard of care.” Dr. Bates-Jensen is nationally known for her work in wound and pressure ulcer care.

The Joint Commission estimates that in the U.S., 2.5 million patients are treated for pressure ulcers in acute care hospitals each year and the incidence is growing at a significant rate. This does not include data on nursing home patients or other settings for care. The prevalence of pressure ulcers among the elderly is significant – 15% of all elders hospitalized; 11% among nursing home residents; 9% in home health settings and up to 25% of all patients hospitalized in a rehabilitation facility suffering from spinal cord injury, traumatic brain injury, chronic neurologic disorders, burns or multiple trauma. The incidence of pressure ulcers is on the rise in every setting. An illustration of this alarming trend is an 86.4% increase in hospital stays with a secondary diagnosis of pressure ulcers and an increase of hospitalizations by 27.2% where pressure ulcers are the primary diagnosis according to data released by the U.S. Department of Health and Human Services’ Agency for Healthcare Research and Quality in 2006. Adult hospital stays related to pressure ulcers cost $11 billion in 2006. According to current estimates by UCLA researchers, annual expenditures to treat pressure ulcers may approach $17 billion in 2010. The estimated average cost for managing a single full thickness pressure ulcer is $70,000. As the pressure ulcer injury progresses, there is a sharp increase in morbidity and mortality. Each year 60,000 patients die from pressure ulcer complications. Prevention and early detection are key to addressing this medical problem.

BBI will demonstrate the SEM Scanner at Wireless Health 2010. This demonstration will show complete operation of the SEM Scanner including its capability for measuring sub-epidermal moisture as well as its capability for assuring proper operation. This will also include its capability for providing data at the point of care and capability for transporting results to remove information services over local area and wide area wireless systems including smartphone platforms. “The SEM Scanner is now in use daily in nursing home clinical trials in Southern California. The results are inspiring and demonstrate that this combination of new biomedical sensing and Wireless Health principles will be critical in advancing patient care. Importantly, contributing to the success of SEM Scanner development was a team of graduate students and staff researchers of the Wireless Health Institute. Their successful work includes the broad objectives from embedded computing to direct support of clinical trials with a very large patient population,” stated Professors Majid Sarrafzadeh and William Kaiser.

Similarly, BBI is targeting other large chronic and acute conditions with its wireless health technology. Boystak further noted, “BBI’s technology holds great promise for materially reducing health care costs while providing physicians, nurses, technicians and patients with new wireless health tools for early detection, effective and convenient monitoring and management of certain medical conditions in various settings.”

Dr. Vijay Dhir, Dean of the UCLA Henry Samueli School of Engineering and Applied Science, noted “BBI’s cutting edge work and outstanding support of our School, faculty and students is consistent with our mission of bringing novel technology to the market thus benefiting the citizens of California and the rest of the nation.”

“BBI represents a perfect paradigm of how a private sector and academic collaboration can lead to novel products with high impact,” stated Michael B. Flesch, Co-Founder and Managing Member.

About UCLA Henry Samueli School of Engineering and Applied Science - The UCLA Henry Samueli School of Engineering and Applied Science, established in 1945, offers 28 academic and professional degree programs, including an interdepartmental graduate degree program in biomedical engineering. Ranked among the top 10 engineering schools at public universities nationwide, the school is home to eight multimillion-dollar interdisciplinary research centers in wireless sensor systems, nanotechnology, nanomanufacturing and nanoelectronics, all funded by federal and private agencies. For additional information please visit www.hsseas.ucla.edu.

About UCLA’s Wireless Health Institute - Research that led to the UCLA Wireless Health Institute (WHI) began in the mid-1990s with the investments by UCLA researchers in development of the first wireless sensor technology and its immediate applications in healthcare. WHI was been launched in Fall 2008. WHI is centered at the Office of the Vice Chancellor of Research with partners and sponsors including the Schools of Medicine, Nursing, Molecular and Medical Pharmacology, Public Health, the West Los Angeles Veterans Affairs Medical Center, the Anderson Graduate School of Management, the College of Letters and Science, and the Henry Samuel School of Engineering and Applied Science. Co-Directors of WHI include Denise Aberle, M.D. (Medicine), Dr. Bruce Dobkin, M.D. (Neurology), Lillian Gelberg, M.D. (Public Health), William Kaiser Ph.D. (Electrical Engineering), and Majid Sarrafzadeh, Ph.D. (Computer Science). For additional information please visit www.wirelesshealth.ucla.edu.

About BBI - BBI is a wireless health technology company focused on innovating and developing a broad range of wireless health devices, software applications and solutions for cost effective detection, monitoring and treatment of certain acute and chronic medical conditions. The devices will be used externally or will be implantable depending upon the medical indication. The company’s systems consist of sophisticated passive sensors capable of measuring various physiologic, biomechanical and biochemical signals which will be activated with an externally powered probe with data being transmitted wirelessly. BBI exclusively licensed its platform technology consisting of extra-sensors, intra-sensors and inter-sensors, among other features from the Regents of the State of California and UCLA, on a worldwide basis. BBI is privately-held and based in Los Angeles, California. For additional information, please visit www.bruinbiometrics.com.

Contacts

Bruin Biometrics, LLC
Joseph A. Boystak
Managing Member
+1-310-268-9494 x 12
jab@bruinbiometrics.com

Contacts

Bruin Biometrics, LLC
Joseph A. Boystak
Managing Member
+1-310-268-9494 x 12
jab@bruinbiometrics.com